Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H32O4 |
| Molecular Weight | 336.4657 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC[C@H](O)\C=C\C1=C(CCCCCCC(O)=O)C(=O)CC1
InChI
InChIKey=YBHMPNRDOVPQIN-VSOYFRJCSA-N
InChI=1S/C20H32O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h12,14,17,21H,2-11,13,15H2,1H3,(H,23,24)/b14-12+/t17-/m0/s1
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2073680 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8863817 |
71.2 nM [Ki] |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases. | 2004-09 |
|
| Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation. | 1997-01-21 |
|
| Microdetermination of the prostaglandin B1 in human plasma by gas chromatography/selected ion monitoring using [18O]prostaglandin B1 as an internal standard. | 1995-04 |
|
| Prostaglandin A inhibits replication of human immunodeficiency virus during acute infection. | 1991-11 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5280388
Created by
admin on Mon Mar 31 22:15:52 GMT 2025 , Edited by admin on Mon Mar 31 22:15:52 GMT 2025
|
PRIMARY | |||
|
1578554
Created by
admin on Mon Mar 31 22:15:52 GMT 2025 , Edited by admin on Mon Mar 31 22:15:52 GMT 2025
|
PRIMARY | |||
|
13345-51-2
Created by
admin on Mon Mar 31 22:15:52 GMT 2025 , Edited by admin on Mon Mar 31 22:15:52 GMT 2025
|
PRIMARY | |||
|
1TYI1PJ64T
Created by
admin on Mon Mar 31 22:15:52 GMT 2025 , Edited by admin on Mon Mar 31 22:15:52 GMT 2025
|
PRIMARY | |||
|
DTXSID001347609
Created by
admin on Mon Mar 31 22:15:52 GMT 2025 , Edited by admin on Mon Mar 31 22:15:52 GMT 2025
|
PRIMARY | |||
|
27624
Created by
admin on Mon Mar 31 22:15:52 GMT 2025 , Edited by admin on Mon Mar 31 22:15:52 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD